The
proton beam's Bragg peak permits highly conformal radiation of skull base
tumors. This study, prompted by reports of transient (30% each) and permanent (10% each) facial and
trigeminal neuropathy after stereotactic radiosurgery of
vestibular schwannomas with marginal doses of 16-20 Gy, assessed whether
proton beam radiosurgery using a marginal dose of only 12 Gy could control
vestibular schwannomas while causing less neuropathy.
METHODS AND MATERIALS: Sixty-eight patients (mean age 67 years) were treated between 1992 and 1998. The mean
tumor volume was 2.49 cm(3). The dose to the
tumor margin (70% isodose line) was 12 Gy. The prospectively specified follow-up consisted of neurologic evaluation and MRI at 6, 12, 24, and 36 months.
RESULTS: After a mean clinical follow-up of 44 months and imaging follow-up of 34 months in 64 patients, 35
tumors (54.7%) were smaller and 25 (39.1%) were unchanged (
tumor control rate 94%; actuarial control rate 94% at 2 years and 84% at 5 years). Three
tumors enlarged: one shrank after repeated radiosurgery, one remained enlarged at the time of unrelated death, and one had not been imaged for 4 years in a patient who remained asymptomatic at last follow-up. Intratumoral
hemorrhage into one stable
tumor required
craniotomy that proved successful. Thus, 97% of
tumors required no additional treatment. Three patients (4.7%) underwent shunting for
hydrocephalus evident as increased
ataxia. Of 6 patients with functional hearing ipsilaterally, 1 improved, 1 was unchanged, and 4 progressively lost hearing.
Cranial neuropathies were infrequent: persistent facial
hypesthesia (2 new, 1 exacerbated; 4.7%); intermittent facial
paresthesias (5 new, 1 exacerbated; 9.4%); persistent facial weakness (2 new, 1 exacerbated; 4.7%) requiring oculoplasty; transient partial facial weakness (5 new, 1 exacerbated; 9.4%), and
synkinesis (5 new, 1 exacerbated; 9.4%).
CONCLUSION: